by The global Blood preparation market size was estimated to be around US$ 48.53 billion in 2022. It is projected to reach US$ 81.99 billion by 2032, indicating a CAGR of 6% from 2023 to 2032.
Key Takeaways
- North America contributed more than 45% of revenue share in 2022.
- Asia Pacific is expected to witness the fastest growth rate in the blood preparation market during the forecast period.
- By product, the whole blood segment held the largest share of the blood preparation market in 2022.
- The blood derivatives segment is expected to grow at a significant compounded annual growth (CAGR) rate during the forecast period.
- By application, the thrombocytosis segment accounted for a larger share in 2022.
- The angina blood vessel complications segment is estimated to grow with a notable CAGR during the study period till 2032.
The market research report on the Blood preparation market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of Blood preparation products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.
Get a Sample: https://www.precedenceresearch.com/sample/3551
Blood Preparation Market Scope
| Report Coverage | Details |
| Growth Rate from 2023 to 2032 | CAGR of 6% |
| Market Size in 2023 | USD 48.53 Billion |
| Market Size by 2032 | USD 81.99 Billion |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product, By Antithrombotic and Anticoagulants Type, By Application, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read More: Molecular Biology Enzymes Market Size to Garner USD 58.83 Billion by 2032
The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.
Focusing on the global Blood preparation market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the Blood preparation market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.
Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of Blood preparation products across different countries and applications.
Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.
The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.
This in-depth research report offers valuable insights into the Blood preparation market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.
The competitive landscape section of the report provides detailed information on Blood preparation market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the Blood preparation market.
Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report
Reasons to Purchase this Report:
- Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
- In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
- Market size in USD million and volume in million units provided for each segment and sub-segment.
- Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
- Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.
Blood Preparation Market Players
- AstraZeneca plc
- Baxter International Inc
- Bristol-Myers Squibb Company
- Celgene Corp.
- GlaxoSmithKline PLC
- Leo Pharma A/S
- Pfizer, Inc.
- Portola Pharmaceuticals, Inc.
- Sanofi
- Shandong East Chemical Industry Co.
- Xiamen Hisunny Chemical Co., LTD
Segments Covered in the Report
By Product
- Whole blood
- Granulocytes
- Red blood cells
- Plasma
- Platelets
- Blood components
- Leukocyte reduced red blood cells
- Packed red blood cells
- Frozen plasma
- Platelet concentrates
- Cryoprecipitate
- Blood derivatives
By Antithrombotic and Anticoagulants Type
- Platelet aggregation inhibitors
- Glycoprotein inhibitors
- ADP antagonists
- COX inhibitors
- Others
- Fibrinolytics
- Streptokinase
- Tissue plasminogen activator (tPA)
- Urokinase
- Anticoagulants
- Heparins
- Low molecular weight heparin (LMWH)
- Unfractionated heparin
- Ultra-low molecular weight heparin
- Direct thrombin inhibitors
- Vitamin K antagonists
- Direct factor Xa inhibitors
- Heparins
By Application
- Thrombocytosis
- Renal impairment
- Pulmonary embolism
- Angina blood vessel complications
- Others
By End User
- Clinics
- Hospitals
- Diagnostic centers
- Research labs
- Blood banks
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Blood Preparation Market
5.1. COVID-19 Landscape: Blood Preparation Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Blood Preparation Market, By Product
8.1. Blood Preparation Market Revenue and Volume Forecast, by Product, 2023-2032
8.1.1. Whole blood
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Blood components
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Blood derivatives
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Blood Preparation Market, By Antithrombotic and Anticoagulants Type
9.1. Blood Preparation Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type, 2023-2032
9.1.1. Platelet aggregation inhibitors
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Fibrinolytics
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Anticoagulants
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Blood Preparation Market, By Application
10.1. Blood Preparation Market Revenue and Volume Forecast, by Application, 2023-2032
10.1.1. Thrombocytosis
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Renal impairment
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Pulmonary embolism
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
10.1.4. Angina blood vessel complications
10.1.4.1. Market Revenue and Volume Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Blood Preparation Market, By End User
11.1. Blood Preparation Market Revenue and Volume Forecast, by End User, 2023-2032
11.1.1. Clinics
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Hospitals
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
11.1.3. Diagnostic centers
11.1.3.1. Market Revenue and Volume Forecast (2020-2032)
11.1.4. Research labs
11.1.4.1. Market Revenue and Volume Forecast (2020-2032)
11.1.5. Blood banks
11.1.5.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Blood Preparation Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.1.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.1.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.1.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.1.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.1.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.1.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.2.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.2.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.2.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.7.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.2.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.2.8.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.2.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.3.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.3.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.3.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.7.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.3.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.3.8.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.3.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.4.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.4.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.7.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.4.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.4.8.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.4.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.5.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.5.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
12.5.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)
12.5.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
Chapter 13. Company Profiles
13.1. AstraZeneca plc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Baxter International Inc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Bristol-Myers Squibb Company
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Celgene Corp.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. GlaxoSmithKline PLC
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Leo Pharma A/S
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Pfizer, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Portola Pharmaceuticals, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Sanofi
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Shandong East Chemical Industry Co.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
